All About Grants Podcast: Considerations for a Research Plan
Dr. Kentner Singleton, NIAID Dr. Lillian Kuo, NCI Thanks to a suggestion from a listener, in this NIH All About Grants episode (MP3 / Transcript) a duo of NIH program officers, Drs. Lillian Kuo from the National Cancer Institute and Kentner Singleton from the National Institute of Allergy and Infectious Diseases, share their advice and experience on developing a research plan for a grant application. They discuss the relationship between the specific aims and research strategy, provide suggestions for when you sit down to start writing, and share common pitfalls. More helpful advice on writing your application is available...
Source: NIH Extramural Nexus - February 22, 2021 Category: Research Authors: NIH Staff Tags: New Resources podcast Research Strategy Specific Aims strategic plan Source Type: funding

Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-022 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide an opportunity for the Regional Biocontainment Laboratories (RBLs) established by the National Institute of Allergy and Infectious Diseases (NIAID) to request support for upgrades to existing facilities and building systems to facilitate the conduct of biomedical research on infectious diseases, including infectious disease outbreaks. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2021 Category: Research Source Type: funding

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Funding Opportunity PAR-21-120 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 17, 2021 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research
Notice NOT-AI-21-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 12, 2021 Category: Research Source Type: funding

Human Immunology Project Consortium (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-20-079 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) for the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, vaccine adjuvants or natural infections by capitalizing on recent advances in immune profiling technologies. Studies supported under this FOA will me...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 8, 2021 Category: Research Source Type: funding

Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-078 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development, and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens, and environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologists ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding

Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens or environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologists to ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding

Notice to Extend Expiration Date for PAR-19-362: Planning Grant for Global Infectious Disease Research Training Program (D71 - Clinical Trials Not Allowed)
Notice NOT-TW-21-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2021 Category: Research Source Type: funding

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 20, 2020 Category: Research Source Type: funding

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-21-030 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB), and Office of AIDS Research (OAR). The goal of this initiative is to encourage the scientific community...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2020 Category: Research Source Type: funding

Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-291 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-290 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Small Research Grant (R03) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R03 grant mechanism supports different types ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

Ecology and Evolution of Infectious Diseases (EEID) Program 2020 – US-UK, China and Israel call for proposals
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - September 1, 2020 Category: Research Source Type: funding

Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
Notice NOT-TW-20-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2020 Category: Research Source Type: funding

Institute and Center Award Rates and Funding Disparities
In 2011, Ginther et al. first demonstrated that African American and Black applicants to the National Institutes of Health received grant awards at a lower rate than their white counterparts (Ginther 2011). Since then, multiple studies have reproduced and extended this finding (Ginther 2011; Ginther 2016; Hoppe 2019; Erosheva 2020). Recently we reported that African American and Black (AAB) PIs are more likely to propose research on topics that are less likely  to be funded (Hoppe 2019). We found that topic choice has little or no effect on whether an application is chosen for discussion, but after consideri...
Source: NIH Extramural Nexus - August 12, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Funding data Source Type: funding

Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels)
Available Formats: HTML: https://www.nsf.gov/pubs/2020/nsf20105/nsf20105.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2020/nsf20105/nsf20105.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf20105This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 16, 2020 Category: Science Source Type: funding

Ecology and Evolution of Infectious Diseases (EEID)
Available Formats: HTML: https://www.nsf.gov/pubs/2020/nsf20585/nsf20585.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2020/nsf20585/nsf20585.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf20585This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 13, 2020 Category: Science Source Type: funding

Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for an immunologic reagent resource to support and facilitate the optimal use of nonhuman primate (NHP) models for vaccine and adjuvant development, transplantation, and infectious and immune-mediated diseases. This resource will identify, obtain, develop, characterize, evaluate, produce, and distribute to the scientific community key immunologic reagents for NHP research that are not commercially available or, if commercially available, are not optimized for use in NHPs. In addi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2020 Category: Research Source Type: funding

Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-036 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is soliciting applications to support research on HIV cure in pediatric populations. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. The cure of HIV infection in people living with HIV (PLWH) is one of the highest priorities of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The goal of the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 15, 2020 Category: Research Source Type: funding

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Funding Opportunity PAR-20-229 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 10, 2020 Category: Research Source Type: funding

SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Advanced Technology Training (ATT) products for: the health and safety training of hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biosafety response, infectious disease training and cleanup; emergency responders in disasters and resiliency training...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 20, 2020 Category: Research Source Type: funding

New “All About Grants” Podcast – All About Contracts
George Kennedy, NIAID Brian O’Laughlin, NIDA Yes, we are talking about contracts in this next installment of the NIH’s All About Grants podcast series. Our guests will be George Kennedy and Brian O’Laughlin, who are acquisition staff from the National Institute of Allergy and Infectious Diseases and National Institute of Drug Abuse, respectively. The conversation (MP3 / Transcript) will introduce you to the world of contracts at NIH, what they are, how they differ from grants, where to find them, what types of research are solicited, tidbits to focus on when developing a proposal, and more. Check out the...
Source: NIH Extramural Nexus - May 12, 2020 Category: Research Authors: NIH Staff Tags: New Resources All About Grants contracts podcast research and development Source Type: funding

NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)
Notice NOT-ES-20-017 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 10, 2020 Category: Research Source Type: funding

Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)"
Notice NOT-ES-20-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 8, 2020 Category: Research Source Type: funding

Nurse Education, Practice, Quality and Retention Simulation Education Training Program
Funding to enhance nursing education and strengthen the nursing workforce through experiential learning opportunities, including the use of simulation-based technology to improve the health of patients, families, and communities in rural and medically underserved areas experiencing diseases and conditions that affect public health. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services (Source: AIDS and HIV funding opportunities via the Rural Assistance Center)
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - April 6, 2020 Category: Infectious Diseases Source Type: funding

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-026 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 6, 2020 Category: Research Source Type: funding

Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)
Notice NOT-ES-20-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 27, 2020 Category: Research Source Type: funding

Notice of Clarification of Additional Considerations listed in NIAID RFA-AI-20-009, Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
Notice NOT-AI-20-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 17, 2020 Category: Research Source Type: funding

Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
Funding Opportunity RFA-AI-20-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2020 Category: Research Source Type: funding

Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will establish Human Biomimetics for Infectious Diseases Cooperative Research Centers (Biomimetics CRCs) focused on multidisciplinary research advancing and/or developing innovative in vitro human-cell- or -tissue-derived three-dimensional (3D) models for basic and translational research on infectious diseases. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2020 Category: Research Source Type: funding

Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine and Treatment Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the In...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2020 Category: Research Source Type: funding

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-108 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of high-priority, regionally relevant infectious disease research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Eligibility status of applicant organizations will be determined by this World Bank Classification li...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 4, 2020 Category: Research Source Type: funding

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-063 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-20-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch(MPIDB) and Office of AIDS Research (OAR). The goal of this initiative is to continue the encouragement of the sc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2019 Category: Research Source Type: funding

Ecology and Evolution of Infectious Diseases (EEID) Program 2019 US-UK, China and Israel call for proposals
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - September 5, 2019 Category: Research Source Type: funding

Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed)
Funding Opportunity PAR-19-362 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for a planning grant from institutions in low- and middle-income countries (LMICs) to 1.) Design a Global Infectious Disease (GID) Research Training Program in collaboration with U.S. collaborators and 2.) Strengthen LMIC faculty and prepare advanced courses and training resources for the program envisioned at the LMIC institution. The application should propose a collaborative process to create a new training program that will strengthen the capacity of the LMIC institution to co...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 3, 2019 Category: Research Source Type: funding

Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
Notice NOT-TW-19-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 28, 2019 Category: Research Source Type: funding

Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-351 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 20, 2019 Category: Research Source Type: funding

MRC-AMED Infectious Disease Research Collaboration
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - June 17, 2019 Category: Research Source Type: funding

Sample Grant Applications, Summary Statements, and More
If you are new to writing grant applications, sometimes seeing how someone else has presented their idea can help as you are developing your own application. With the gracious permission of successful investigators, the National Institute of Allergy and Infectious Diseases (NIAID) makes available examples of funded R01, R03, R15, R21, SBIR/STTR, K, and F applications, summary statements, sharing plans, leadership plans, and more. When referencing these resources, it is important to remember: These applications were developed using the application forms and instructions that were in effect at the time of their submission...
Source: NIH Extramural Nexus - May 1, 2019 Category: Research Authors: NIH Staff Tags: Tips Before You Submit grant tips sample application Source Type: funding

SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-19-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Advanced Technology Training (ATT) products for: the health and safety training of hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biosafety response, infectious disease training and cleanup; emergency responders in disasters and resiliency training...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2019 Category: Research Source Type: funding

Notice of Budget Change in RFA-AI-19-028 Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
Notice NOT-AI-19-056 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2019 Category: Research Source Type: funding

U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding

U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. This opportunity is specifically designed to promote partnerships between eligible NIH Intramural Research Program (IRP) investigators (e.g. those conducting research within the laborato...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding

Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish a coordinated network of Emerging Infectious Disease Research Centers (EIDRCs) in regions around the globe where emerging and re-emerging infectious disease outbreaks are likely to occur. Multidisciplinary teams of investigators will conduct pathogen/host surveillance, study pathogen transmission, pathogenesis and immunologic responses in the host, and will develop reagents and diagnostic assays for improved detection for important emerging pathogens and their vectors. (...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 5, 2019 Category: Research Source Type: funding

Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-029 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for an Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC) for the Emerging Infectious Diseases Research Centers (EIDRC). The EIDRC CC will oversee and coordinate select aspects of each EIDRCs research project(s) involving data management, sample collection and storage, sharing of reagents, diagnostics, and resources, and will facilitate collaboration between the newly awarded EIDRCs, and other USG and international agencies, as approp...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 4, 2019 Category: Research Source Type: funding

U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-18-054 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote collaborative biomedical research between the United States and Brazil under the U.S.-Brazil Biomedical Collaborative Research Program. Research areas supported under this program include allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities; cancer; mother-to-child transmission of HIV and other congenital infections, early infant diagnosis and treatment; HIV/AIDS in relation to mental health; and neurological disorders and stroke. (Source...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2018 Category: Research Source Type: funding

Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
Funding Opportunity PA-19-068 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support projects that utilize open-access data, alone or in combination with other datasets, to address knowledge gaps in basic and clinical infectious diseases. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2018 Category: Research Source Type: funding

Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
Funding Opportunity PA-19-066 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to determine antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands and to determine the contribution of these unique antigenic ligands to protective immune responses against infectious disease pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or limit progression or induction of immune-mediated diseases. These studies may facilitate the development of novel tools and reagents to advance design of immune-b...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2018 Category: Research Source Type: funding

Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional)
Funding Opportunity PAR-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports planning, design and initial pilots for locally relevant and catalytic research on non-communicable diseases (NCDs) or injury in low and middle-income countries (LMICs). Research addressing multiple NCDs and their risk factors and research addressing NCDs as comorbidities for/with infectious diseases including HIV/AIDS is encouraged. Scientists in the United States (U.S.) or upper middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Income categories used...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2018 Category: Research Source Type: funding